JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Molecular Endocrinology (1994) 13, 347-356    DOI: 10.1677/jme.0.0130347
© 1994 Society for Endocrinology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walli, R
Right arrow Articles by Schmidt, W E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walli, R
Right arrow Articles by Schmidt, W E

Identification and biochemical characterization of the human brain galanin receptor

R Walli, H Schäfer, C Morys-Wortmann, G Paetzold, R Nustede and W E Schmidt

Human galanin (hGal) is an important neuro-modulator present in the brain, gastrointestinal system and the hypothalamo-pituitary axis. A specific receptor for hGal has been identified in various areas in human brain. A single class of high affinity binding sites was found on plasma membranes of the amygdala (Kd 0·23 nM, Bmax 44 fmol/mg), the hypothalamus (Kd 0·20 nM, Bmax 25 fmol/mg) and the cortex cerebri (Kd0·11 nM, Bmax 8·2 fmol/mg). Other brain areas, i.e. cerebellum, thalamus or pons, expressed binding sites of identical high affinity in lower quantities (Bmax <3 fmol/mg). Specific binding of 125I-labelled hGal was found to be reversible, time- and temperature-dependent and inhibited by Ca2+, Na+ and K+ ions at a concentration of 5 mM. Non-hydrolysable guanosine nucleotides potently reduced specific binding of 125I-labelled hGal by more than 80%. Synthetic hGal analogues substituted in the N-terminal region exhibited strongly reduced binding affinity for the hGal receptor. Using 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy-1-propanesulphonate, hGal receptors were successfully solubilized from human cortical membranes, exhibiting no significant loss of binding affinity. Affinity cross-linking to 125I-labelled hGal revealed a labelled band of approximately 60 kDa sensitive to unlabelled Gal. This putative hGal receptor is glycosylated since its molecular size was reduced after treatment with endoglycosidase F. Receptors bound to 125I-labelled hGal could be specifically adsorbed to wheat germ agglutinin and ricinus communis agglutinin, suggesting that receptor glycosylation involves N-acetyl glucosamine and galactose respectively.




This article has been cited by other articles:


Home page
DiabetesHome page
W.-D. Li, C. Dong, D. Li, C. Garrigan, and R. A. Price
A Quantitative Trait Locus Influencing Fasting Plasma Glucose in Chromosome Region 18q22-23
Diabetes, September 1, 2004; 53(9): 2487 - 2491.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Giustina and J. D. Veldhuis
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human
Endocr. Rev., December 1, 1998; 19(6): 717 - 797.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
L. W. Fitzgerald, J. P. Patterson, D. S. Conklin, R. Horlick, and B. L. Largent
Pharmacological and Biochemical Characterization of a Recombinant Human Galanin GALR1 Receptor: Agonist Character of Chimeric Galanin Peptides
J. Pharmacol. Exp. Ther., November 1, 1998; 287(2): 448 - 456.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the Society for Endocrinology.